{"id":318564,"date":"2021-09-20T12:50:46","date_gmt":"2021-09-20T12:50:46","guid":{"rendered":"http:\/\/radiofree.asia\/?guid=376c841135a590c03ce9a3ee555c6a5e"},"modified":"2021-09-20T12:50:46","modified_gmt":"2021-09-20T12:50:46","slug":"indian-civil-society-urges-johnson-johnson-to-stop-exporting-indian-made-vaccines-to-rich-nations-2","status":"publish","type":"post","link":"https:\/\/radiofree.asia\/2021\/09\/20\/indian-civil-society-urges-johnson-johnson-to-stop-exporting-indian-made-vaccines-to-rich-nations-2\/","title":{"rendered":"Indian Civil Society Urges Johnson &amp; Johnson to Stop Exporting Indian-Made Vaccines to Rich Nations"},"content":{"rendered":"\n        <a href=\"http:\/\/www.democracynow.org\/2021\/9\/20\/covid_vaccine_inequity_achal_prabhala\"><img style=\"float:right; padding-left:5px;\" src=\"https:\/\/www.democracynow.org\/images\/story\/54\/59554\/w320\/SEG3-Vaccine-3.jpg\" alt=\"Seg3 vaccine 3\" \/><\/a><p>More than a dozen civil society groups in India have written an open letter to Johnson &amp; Johnson and the U.S. government, urging the pharmaceutical giant to cancel export of Indian-made <span class=\"caps\">COVID<\/span>-19 vaccine doses to rich countries and instead focus on distributing them in the Global South. &#8220;The 600 million doses that Johnson &amp; Johnson is manufacturing currently \u2026 in India should go where the vaccines are most needed, which is the Indian subcontinent, the African continent and the <span class=\"caps\">COVAX<\/span> Facility,&#8221; says public health activist Achal Prabhala, who co-authored the letter and is coordinator of the AccessIBSA project, which campaigns for access to medicines in India, Brazil and South Africa.<\/p>\n      \n<p class=\"syndicated-attribution\">This post was originally published on <a href=\"http:\/\/www.democracynow.org\/2021\/9\/20\/covid_vaccine_inequity_achal_prabhala\">Democracy Now!<\/a>. <\/p>","protected":false},"excerpt":{"rendered":"<p>More than a dozen civil society groups in India have written an open letter to Johnson &amp; Johnson and the U.S. government, urging the pharmaceutical giant to cancel export of Indian-made COVID-19 vaccine doses to rich countries and instead focus on distributing them in the Global South. &#8220;The 600 million doses that Johnson &amp; Johnson is manufacturing currently \u2026 in India should go where the vaccines are most needed, which is the Indian subcontinent, the African continent and the COVAX Facility,&#8221; says public health activist Achal Prabhala, who co-authored the letter and is coordinator of the AccessIBSA project, which campaigns for access to medicines in India, Brazil and South Africa.<\/p>\n","protected":false},"author":1293,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"_links":{"self":[{"href":"https:\/\/radiofree.asia\/wp-json\/wp\/v2\/posts\/318564"}],"collection":[{"href":"https:\/\/radiofree.asia\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/radiofree.asia\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/radiofree.asia\/wp-json\/wp\/v2\/users\/1293"}],"replies":[{"embeddable":true,"href":"https:\/\/radiofree.asia\/wp-json\/wp\/v2\/comments?post=318564"}],"version-history":[{"count":1,"href":"https:\/\/radiofree.asia\/wp-json\/wp\/v2\/posts\/318564\/revisions"}],"predecessor-version":[{"id":318565,"href":"https:\/\/radiofree.asia\/wp-json\/wp\/v2\/posts\/318564\/revisions\/318565"}],"wp:attachment":[{"href":"https:\/\/radiofree.asia\/wp-json\/wp\/v2\/media?parent=318564"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/radiofree.asia\/wp-json\/wp\/v2\/categories?post=318564"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/radiofree.asia\/wp-json\/wp\/v2\/tags?post=318564"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}